UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

JAMA : the journal of the American Medical Association, 2006-01, Vol.295 (3), p.293

2006

Volltextzugriff (PDF)

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

Nature reviews. Drug discovery, 2010-07, Vol.9 (7), p.519-522

2010

Volltextzugriff (PDF)

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

Annals of internal medicine, 2003-05, Vol.138 (10), p.807

2003

Volltextzugriff (PDF)

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007

Pediatrics (Evanston), 2008-06, Vol.121 (6), p.1206-1212

2008

Volltextzugriff (PDF)

Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

American journal of preventive medicine, 2010-10, Vol.39 (4), p.296-304

2010

Volltextzugriff (PDF)

Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007

The Pediatric infectious disease journal, 2009-11, Vol.28 (11), p.943-947

2009

Volltextzugriff (PDF)

Answering Key Questions About COVID-19 Vaccines

JAMA : the journal of the American Medical Association, 2020-11, Vol.324 (20), p.2027

2020

Volltextzugriff (PDF)

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005

Vaccine, 2007-05, Vol.25 (21), p.4244-4251

2007

Volltextzugriff (PDF)

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents

Journal of rheumatology, 2004-10, Vol.31 (10), p.1955

2004

Volltextzugriff (PDF)

Toward better vaccine safety data and safer vaccination

Pediatrics (Evanston), 2008-03, Vol.121 (3), p.625-626

Braun, M Miles

2008

Volltextzugriff (PDF)

Orphan products: an emerging trend in drug approvals

Nature reviews. Drug discovery, 2010-01, Vol.9 (1), p.84-84

2010

Volltextzugriff (PDF)

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

JAMA : the journal of the American Medical Association, 2009-08, Vol.302 (7), p.750

2009

Volltextzugriff (PDF)

Infectious complications of biologic treatments of rheumatoid arthritis

Current opinion in rheumatology, 2003-05, Vol.15 (3), p.179-184

2003

Volltextzugriff (PDF)

Adverse event reports following yellow fever vaccination

Vaccine, 2008-11, Vol.26 (48), p.6077-6082

2008

Volltextzugriff (PDF)

Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

Journal of the American Academy of Dermatology, 2005-09, Vol.53 (3), p.407-415

2005

Volltextzugriff (PDF)

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

The Pediatric infectious disease journal, 2004-04, Vol.23 (4), p.287-294

2004

Volltextzugriff (PDF)

Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor

Clinical infectious diseases, 2004-08, Vol.39 (3), p.295-299

2004

Volltextzugriff (PDF)

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization

Journal of allergy and clinical immunology, 2004-03, Vol.113 (3), p.536-542

2004

Volltextzugriff (PDF)

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration

Journal of bone and joint surgery. American volume, 2006-03, Vol.88 (3), p.503

2006

Volltextzugriff (PDF)

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

JAMA : the journal of the American Medical Association, 2005-12, Vol.294 (21), p.2720

2005

Volltextzugriff (PDF)

Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases

Vaccine, 2007-02, Vol.25 (10), p.1727-1734

2007

Volltextzugriff (PDF)

What Should an Ideal Vaccine Postlicensure Safety System Be?

American journal of public health (1971), 2009-10, Vol.99 (S2), p.S345-S350

2009

Volltextzugriff (PDF)

Varicella–Zoster Vaccine

The New England journal of medicine, 2007-07, Vol.357 (1), p.88-90

2007

Volltextzugriff (PDF)

Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system

The Pediatric infectious disease journal, 2001-02, Vol.20 (2), p.219-223

2001

Volltextzugriff (PDF)

Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

Drug discovery today, 2011, Vol.16 (1), p.73-80

2011

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(110)

Sprache

Englisch
(110)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(109)
Science & Technology
(98)
Life Sciences & Biomedicine
(97)
Male
(64)
Female
(57)
Biological And Medical Sciences
(52)
Medical Sciences
(48)
Adult
(42)
United States
(39)
Middle Aged
(38)
Infant
(32)
Adverse Drug Reaction Reporting Systems
(31)
Aged
(30)
Infectious Diseases
(28)
Adolescent
(27)
Child, Preschool
(25)
Immunology
(25)
Child
(24)
Vaccines
(24)
United States - Epidemiology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007

Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007

Answering Key Questions About COVID-19 Vaccines

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents

Toward better vaccine safety data and safer vaccination

Orphan products: an emerging trend in drug approvals

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

Infectious complications of biologic treatments of rheumatoid arthritis

Adverse event reports following yellow fever vaccination

Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases

What Should an Ideal Vaccine Postlicensure Safety System Be?

Varicella–Zoster Vaccine

Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system

Characteristics of orphan drug applications that fail to achieve marketing approval in the USA

Aktive Filter

Suchergebnisse filtern